Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study

Abstract

These observational data suggest that NOAC treatment may be associated with a positive net clinical benefit compared with no treatment or VKA treatment in patients at low stroke risk, a question that can be tested through a randomized controlled trial.